- A 21 August 2026 review re-examined bakuchiol against retinol and asked for clearer labels.
- In 44 people over 12 weeks, 0.5 percent bakuchiol and 0.5 percent retinol showed similar shifts in wrinkles and pigment.
- Retinol brought more scaling and stinging, while sourcing and dose still vary widely across products.
Forty four people completed the comparison that still shapes the discussion, and on 21 August 2026 AutyFIT Editorial published an evidence review that returned to that trial and urged clearer statements on packs and shelves. The review focused on a 12 week head to head study from 2019.
Readers who cannot stay with nightly retinol get a limited but practical signal. In the best controlled comparison, signs of photoageing changed by a similar amount and tolerance favoured bakuchiol. That outcome applies to a single tested routine. It does not rank every bakuchiol serum against retinol.
The starting material needs attention first. Bakuchiol is a meroterpene phenol from the seeds and leaves of Psoralea corylifolia, also called Cullen corylifolium. Seed oil, a low level extract and high purity bakuchiol are separate ingredients. A 2020 Pierre Fabre study reported its bakuchiol raw material at approximately 95 percent purity.
The trial design was tight and particular. Registration on ClinicalTrials.gov used NCT03112863. The protocol tested 0.5 percent bakuchiol twice daily against 0.5 percent retinol once daily for 12 weeks in 44 participants. Both arms showed significant decreases in wrinkle surface area and hyperpigmentation, with no statistical difference between compounds on those measures. One summary put the change at 20 to 30 percent reductions in fine lines and hyperpigmentation.
Tolerance produced the clearest split between routines. People assigned to retinol reported more facial scaling and stinging than people assigned to bakuchiol. In the British Journal of Dermatology in 2019, Chaudhuri and Bojanowski wrote that bakuchiol matched retinol for photoageing with better tolerability.
Mechanism data support curiosity without proving equivalence. Retinol converts to retinoic acid in skin and binds retinoid receptors, whereas bakuchiol does not convert to retinoic acid. Gene expression research from 2014 found bakuchiol activated downstream collagen boosting pathways while suppressing MMPs that break down collagen. Later reviews lean the same direction. A review in the Journal of Integrative Dermatology searched PubMed and EMBASE for bakuchiol and photoaging, included seven articles from 2014 to 2021, and found comparable efficacy and better tolerability than retinol in direct comparison. A 2024 comparative study in the Journal of Cosmetic Dermatology reported comparable efficacy for photoaging and hyperpigmentation at 12 weeks with fewer reports of redness and scaling.
Dose and sourcing remain the issues to check. Because the head to head used different regimens, it tested routines rather than gram for gram potency. Product copy often merges cell, animal and human findings into one studies show statement, which claims more than cosmetic trials measured. A 2025 market analysis by Grand View Research projected the global bakuchiol market to grow at a compound annual growth rate of 7.5 percent through 2030, which may mean more formulas with less clarity.
For now, view bakuchiol as one option where tolerance matters, not a full substitute for each retinoid outcome.
Benjamin Marsh
Benjamin looks after the brands Face Value works with and makes sure every sponsored page is labelled as one. He spent six years on the commercial side of a New Jersey contract lab, which is where he learned what a stability test costs.
More from Benjamin Marsh →
